Generium Alternatives & Competitors

12 companies similar to Generium — Our ideas to save life and health

CMAB Biopharma

Exclusively focused on delivering fully integrated CDMO services for biologics

38 Series B $72.00M

Suzhou, China

Biopharma Biotechnology +1

Sanyou Biopharmaceuticals

Biological Drug R&D, Ask Sanyou Bio

151 Series B

Cambridge, United States

Biotechnology Pharmaceutical

Juventas Cell Therapy Corp.

32 Series C $533.74M

China

Biotechnology Health Care +1

Acticor Biotech

To treat the acute phase of ischemic stroke !

18 Post-IPO Equity $49.30M

Paris, France

Biopharma Biotechnology +2

Track all Generium competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

trenzyme GmbH

As full service provider for the life science industry, we have a clear mission: Accelerat...

Konstanz, Germany

Biotechnology Life Sciences +1

Lightcast

Profiling function, cell by cell.

96 Series B $39.30M

Cambridge, United Kingdom

Biotechnology

BIOSIDUS

Pioneros y Líderes en Biosimilares en Mercados Emergentes

504 Private Equity

Argentina

Biotechnology Manufacturing +1

Halda Therapeutics

Taking Hold, Conquering Cancer. Discovering novel medicines to target cancer and overcome...

39 Acquired $3.18B

New Haven, United States

Biotechnology

Nordmark Pharma GmbH

Full Solution Partner für biopharmazeutische Wirkstoffe und Arzneimittel

264

Uetersen, Germany

Biotechnology Food and Beverage +2

Candid Therapeutics

Developing innovative therapeutics that can materially improve the lives of patients

46 Acquired $2.37B

San Diego, United States

Biotechnology Pharmaceutical

Panacela Labs

Fostering biomedical breakthroughs for oncology and rare diseases through global collabora...

3 Series B $39.90M

Biotechnology Health Care

53Biologics

Decoding Biologics Production

29 Venture round $7.00M

Valladolid, Spain

Biotechnology Manufacturing

About Generium

Generium is a full-cycle innovative high-end pharmaceutical company with a focus on saving lives and promoting health. Established in 2009, it has emerged as a leader in the Russian orphan pharmaceutical market. The company's core strength lies in its in-house R&D park, capable of handling the entire development cycle...

Business keywords

Biopharmaceuticals, Biotechnology Research, Orphan Drug Development, Innovative Drug Manufacturing, Biomedical Cell Products, R&D Collaboration, GMP Standards, Full-cycle Pharmaceutical Production

Frequently Asked Questions

Companies similar to Generium include CMAB Biopharma, Sanyou Biopharmaceuticals, Juventas Cell Therapy Corp., Acticor Biotech, trenzyme GmbH. They work in Biotechnology and share Generium's focus on biopharmaceuticals, gmp standards and biotechnology research.

Bounce Watch lists 12 companies that share Generium's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Generium and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Generium Profile CMAB Biopharma Alternatives Sanyou Biopharmaceuticals Alternatives Juventas Cell Therapy Corp. Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Generium on 15 Nov 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.